ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA – Get Free Report) was the target of a large increase in short interest in November.
Clin Lipidology. 2012;7(4):363-365. The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the ...